(5Z)-5-[(1,3-benzodioxo-5-yl)methylene]-3-methyl-2-[2-(Z)-(4-nitrobenzylideneamino)ethylamino]-3,5-dihydro-4H-imidazol-4-one

ID: ALA1081737

Chembl Id: CHEMBL1081737

PubChem CID: 135860189

Max Phase: Preclinical

Molecular Formula: C21H19N5O5

Molecular Weight: 421.41

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCC/N=C/c1ccc([N+](=O)[O-])cc1

Standard InChI:  InChI=1S/C21H19N5O5/c1-25-20(27)17(10-15-4-7-18-19(11-15)31-13-30-18)24-21(25)23-9-8-22-12-14-2-5-16(6-3-14)26(28)29/h2-7,10-12H,8-9,13H2,1H3,(H,23,24)/b17-10-,22-12+

Standard InChI Key:  GCALWFPYGHRAMO-AUQONHRFSA-N

Alternative Forms

  1. Parent:

    ALA1081737

    ---

Associated Targets(Human)

CSNK2B Tbio Casein kinase I isoform alpha/subunit beta (18 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK5 Tchem Cyclin-dependent kinase 5/CDK5 activator 1 (3697 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GSK3A Tclin Glycogen synthase kinase-3 (736 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 421.41Molecular Weight (Monoisotopic): 421.1386AlogP: 2.20#Rotatable Bonds: 6
Polar Surface Area: 118.66Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.64CX LogP: 2.56CX LogD: 2.55
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.25Np Likeness Score: -0.83

References

1. Debdab M, Renault S, Lozach O, Meijer L, Paquin L, Carreaux F, Bazureau JP..  (2010)  Synthesis and preliminary biological evaluation of new derivatives of the marine alkaloid leucettamine B as kinase inhibitors.,  45  (2): [PMID:19879673] [10.1016/j.ejmech.2009.10.009]

Source